Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.842281
Abstract: Background We conducted this study to evaluate if a reduced cumulative dose of induction and concurrent cisplatin conferred similar favorable outcomes when compared to trial NPC-0501. Methods Newly diagnosed nasopharyngeal carcinoma (NPC) with stage III-IVA…
read more here.
Keywords:
nasopharyngeal carcinoma;
reduced cumulative;
trial;
cisplatin ... See more keywords